Cargando…
Dopamine Buffering Capacity Imaging: A Pharmacodynamic fMRI Method for Staging Parkinson Disease
We propose a novel pharmacological fMRI (phMRI) method for objectively quantifying disease severity in Parkinson disease (PD). It is based on the clinical observation that the benefit from a dose of levodopa wears off more quickly as PD progresses. Biologically this has been thought to represent dec...
Autores principales: | Black, Kevin J., Acevedo, Haley K., Koller, Jonathan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232584/ https://www.ncbi.nlm.nih.gov/pubmed/32477245 http://dx.doi.org/10.3389/fneur.2020.00370 |
Ejemplares similares
-
Identification of the Early Stage of Alzheimer's Disease Using Structural MRI and Resting-State fMRI
por: Hojjati, Seyed Hani, et al.
Publicado: (2019) -
Application of DTI and fMRI in moyamoya disease
por: Hao, Xiaokuan, et al.
Publicado: (2022) -
Dynamic Alterations of Spontaneous Neural Activity in Parkinson's Disease: A Resting-State fMRI Study
por: Zhang, Chao, et al.
Publicado: (2019) -
Simultaneous EEG-fMRI for Functional Neurological Assessment
por: Mele, Giulia, et al.
Publicado: (2019) -
Why is Clinical fMRI in a Resting State?
por: O'Connor, Erin E., et al.
Publicado: (2019)